HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd.

ABSTRACT:

SUBMITTER: Singer CF 

PROVIDER: S-EPMC11999886 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature